Viewing StudyNCT01874288



Ignite Creation Date: 2024-05-06 @ 1:42 AM
Last Modification Date: 2024-10-26 @ 11:08 AM
Study NCT ID: NCT01874288
Status: TERMINATED
Last Update Posted: 2020-11-24
First Post: 2013-06-07

Brief Title: A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL
Sponsor: Alopexx Oncology LLC
Organization: Alopexx Oncology LLC

Conditions & Keywords Data

Conditions:
Name
B-cell Non-Hodgkin Lymphoma
Keywords:
Name View
IL interleukin View
NHL View
Immunocytokine View
Lymphoma View
Non-Hodgkin View
B-cell View